Literature DB >> 13406048

Incorporation of N15-L-aspartic acid into the abnormal serum and urine proteins of multiple myeloma; studies of the inter-relationship of these proteins.

E F OSSERMAN, A GRAFF, M MARSHALL, D LAWLOR, S GRAFF.   

Abstract

Entities:  

Keywords:  ASPARTIC ACID; MYELOMA, PLASMA CELL/metabolism

Mesh：

Substances：

Year:  1957        PMID： 13406048      PMCID： PMC1072647          DOI： 10.1172/JCI103431

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  Abnormal serum and urine proteins in thirty five cases of multiple myeloma, as studied by filter paper electrophoresis.

Authors:  E F OSSERMAN; D P LAWLOR
Journal:  Am J Med       Date:  1955-03       Impact factor: 4.965

2.  Biosynthetic determination with radioactive sulfur of turn-over rates of various plasma proteins in normal and cirrhotic man.

Authors:  W VOLWILER; P D GOLDSWORTHY; M P MACMARTIN; P A WOOD; I R MACKAY; K FREMONT-SMITH
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

3.  Proteins in multiple myeloma. IV. Interaction with metabolic nitrogen.

Authors:  S HARDY; F W PUTNAM
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

4.  Comparative behavior of I131 and C14 labelled albumin in plasma of man.

Authors:  S P MASOUREDIS; M L BEECKMANS
Journal:  Proc Soc Exp Biol Med       Date:  1955-07

5.  Preliminary observations on difference in carbohydrate binding between abnormal serum and urine proteins of multiple myeloma.

Authors:  E F OSSERMAN; D P LAWLOR
Journal:  Science       Date:  1954-10-29       Impact factor: 47.728

6.  The persistence in the blood of the radioactive label of albumin, gamma globulins, globulins of intermediate mobility studied with S35 and paper electrophoresis: methods and preliminary results.

Authors:  S H ARMSTRONG; K McLEOD; J WOLTER; J KUKRAL
Journal:  J Lab Clin Med       Date:  1954-06

7.  Proteins in multiple myeloma. I. Physicochemical study of serum proteins.

Authors:  F W PUTNAM; B UDIN
Journal:  J Biol Chem       Date:  1953-06       Impact factor: 5.157

8.  Proteins in multiple myeloma. II. Bence-Jones proteins.

Authors:  F W PUTNAM; P STELOS
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

9.  Multiple myeloma. IV. Abnormal serum components and Bence Jones protein.

Authors:  R W RUNDLES; G R COOPER; R W WILLETT
Journal:  J Clin Invest       Date:  1951-10       Impact factor: 14.808

10.  The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808
View more
  3 in total

1.  METABOLISM OF BENCE JONES PROTEINS.

Authors:  A SOLOMON; T A WALDMANN; J L FAHEY; A S MCFARLANE
Journal:  J Clin Invest       Date:  1964-01       Impact factor: 14.808

2.  The biological significance of the anomalous serum and urinary proteins of myelomatosis, lymphoma, and other conditions.

Authors:  J A OWEN; C GOT
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

3.  Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.

Authors:  B A ASKONAS; J L FAHEY
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.